The impact of HIV infection on clinical presentation and mortality among persons with hepatocellular carcinoma in Kampala, Uganda

[1]  A. Aseffa,et al.  Prevalence of HIV and Its Co-Infection with Hepatitis B/C Virus Among Chronic Liver Disease Patients in Ethiopia , 2022, Hepatic medicine : evidence and research.

[2]  J. Ferlay,et al.  Cancer statistics for the year 2020: An overview , 2021, International journal of cancer.

[3]  S. Shin,et al.  Survival in untreated hepatocellular carcinoma: A national cohort study , 2021, PloS one.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  Richard D Moore,et al.  Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015 , 2021, JAMA network open.

[6]  K. Mugisha,et al.  Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study , 2020, PloS one.

[7]  M. Kamya,et al.  High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda , 2020, African health sciences.

[8]  E. Engels,et al.  HIV Infection, Cancer Treatment Regimens, and Cancer Outcomes Among Elderly Adults in the United States. , 2019, JAMA oncology.

[9]  K. Schwab,et al.  The prevalence of schistosomiasis in Uganda: A nationally representative population estimate to inform control programs and water and sanitation interventions , 2019, PLoS neglected tropical diseases.

[10]  H. Friess,et al.  Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study , 2019, Gut.

[11]  M. Zoli,et al.  Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Were,et al.  Risk factors for liver Cancer in HIV endemic areas of Western Kenya , 2018, Infectious Agents and Cancer.

[13]  J. Sterne,et al.  Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies , 2017, The lancet. HIV.

[14]  Uchenna Okonkwo,et al.  Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. , 2017, The lancet. Gastroenterology & hepatology.

[15]  J. Goldman,et al.  A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999–2008 , 2015, Journal of acquired immune deficiency syndromes.

[16]  S. Taylor-Robinson,et al.  Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma , 2015, Nigerian medical journal : journal of the Nigeria Medical Association.

[17]  E. Engels,et al.  Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Tukahebwa,et al.  Schistosoma mansoni and HIV infection in a Ugandan population with high HIV and helminth prevalence , 2015, Tropical medicine & international health : TM & IH.

[19]  D. Klein,et al.  Survival among HIV-Infected and HIV-Uninfected Individuals with Common Non–AIDS-Defining Cancers , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[20]  D. Abrams,et al.  Non-AIDS-Defining Malignancies in the HIV-Infected Population , 2014, Current Infectious Disease Reports.

[21]  M. Kew.  Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. , 2013, Annals of hepatology.

[22]  A. Singal,et al.  Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  M. Diener-West,et al.  Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  M. Kew.  Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment. , 2012, World journal of hepatology.

[25]  H. Whittle,et al.  Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[26]  M. Kew.  Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. , 2010, Pathologie-biologie.

[27]  G. Guaraldi,et al.  Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. , 2011, The oncologist.

[28]  J. Bruix,et al.  A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma , 2010, Hepatology.

[29]  J. Goedert,et al.  Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa , 2010, Journal of viral hepatitis.

[30]  S. Cole,et al.  A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals , 2009, Journal of acquired immune deficiency syndromes.

[31]  J. Bruix,et al.  Major achievements in hepatocellular carcinoma , 2009, The Lancet.

[32]  H. Wabinga,et al.  Trends in the incidence of primary liver cancer in Central Uganda, 1960–1980 and 1991–2005 , 2009, British Journal of Cancer.

[33]  S. Paggi,et al.  Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .

[34]  E. Bini,et al.  Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. , 2007, Journal of hepatology.

[35]  H. Brenner,et al.  Cancer survival in Kampala, Uganda , 2005, British Journal of Cancer.

[36]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[37]  J. Goedert,et al.  The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.

[38]  R. Simon,et al.  A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients , 1975, Cancer.

[39]  N. Giama,et al.  Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma , 2019, The American Journal of Gastroenterology.

[40]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..